A study by an economic think tank ranks Massachusetts as the state best-equipped to capitalize on biotechnology and pharmaceutical growth, a prize that economic development campaigns in 40 states are targeting.While industry officials said the findings released Tuesday by the Santa Monica, Calif.-based Milken Institute validate Massachusetts’ past efforts to foster biotech growth, they warned that increasing competition among states threatens Massachusetts’ leadership.
